Viveve Announces Closing of Public Offering of Shares of Common Stock

Viveve Medical (NASDAQ: VIVE), a medical technology company focused on women’s intimate health, today announced the closing of its previously announced underwritten public offering of 11,500,000 shares of its common stock at a public offering price of $3.00 per share, including shares of common stock issued upon the full exercise by the underwriters of their option to purchase additional shares.

As quoted in the press release:

The net proceeds to Viveve from the offering were approximately $32.4 million, after deducting underwriting discounts and commissions (but before deducting estimated offering expenses payable by the Company). Viveve intends to use the net proceeds from this offering for supporting the commercialization of its products, clinical research and development, working capital and general corporate purposes. All shares sold in the offering were sold by Viveve.

Click here to read the full press release.